Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Published:2020-07-21 Issue:3 Volume:142 Page:306-308
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Faridi Kamil F.¹²,Tamez Hector²,Strom Jordan B.²,Song Yang³,Butala Neel M.⁴,Shen Changyu²,Secemsky Eric A.²,Mauri Laura³⁵,Curtis Jeptha P.¹,Gibson C. Michael²³,Yeh Robert W.²⁴³^ORCID

Affiliation:

1. Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (K.F.F., J.P.C.).

2. Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (K.F.F., H.T., J.B.S., C.S., E.A.S., C.M.G., R.W.Y.).

3. Baim Institute for Clinical Research, Boston, MA (Y.S., L.M., C.M.G., R.W.Y.).

4. Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (N.M.B., R.W.Y.).

5. Medtronic, Minneapolis, MN (L.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

2. Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study

3. Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement

4. A Proportional Hazards Model for the Subdistribution of a Competing Risk

5. Cox-Type Regression Analysis for Large Numbers of Small Groups of Correlated Failure Time Observations

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of administrative claims to identify ultrasound enhancing agent use;Echo Research & Practice;2024-02-07

2. Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study;Journal of the American Heart Association;2023-07-18

3. Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study;Circulation;2023-04-25

4. Harnessing Real-World Evidence to Advance Cancer Research;Current Oncology;2023-02-02

5. Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percutaneous coronary intervention;Coronary Artery Disease;2022-11-22